Litcius/Paper detail

Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease

Jeongeun Hyun, Muthana Al Abo, Rajesh Kumar Dutta, Seh Hoon Oh, Kun Xiang, Xiyou Zhou, Raquel Maeso‐Díaz, Rebecca Caffrey, Arun J. Sanyal, Jennifer A. Freedman, Steven R. Patierno, Cynthia A. Moylan, Manal F. Abdelmalek, Anna Mae Diehl

2021Journal of Hepatology56 citationsDOIOpen Access PDF

Topics & Concepts

CarcinogenesisFatty liverCancer researchInflammationHepatocyteAlcoholic liver diseaseMedicineHippo signaling pathwayChronic liver diseaseBiologyCancerInternal medicineDiseaseKinaseCell biologyCirrhosisGeneticsIn vitroHippo pathway signaling and YAP/TAZRNA Research and SplicingFOXO transcription factor regulation
Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease | Litcius